Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Both sides next revision |
pharmaceutical_companies:roche [2023/05/11 20:52]
liam | pharmaceutical_companies:roche [2023/05/11 20:52] (current)
liam |
|---|
| ==== COVID-19 ==== | ==== COVID-19 ==== |
| |
| On August 19, 2020, Roche and [[Regeneron|Regeneron Pharmaceuticals]] announced a collaboration "on developing and manufacturing REGN-COV2", Regeneron's experimental [[:monoclonal antibody]] cocktail for use against [[:COVID-19]].((Bowie, A. (2020, August 19). //Regenereon and Roche collaborate to significantly increase global supply of REGN-CoV2 investigational antibody cocktail for COVID-19.// Regeneron Pharmaceuticals. https://newsroom.regeneron.com/news-releases/news-release-details/regeneron-and-roche-collaborate-significantly-increase-global)) | On August 19, 2020, Roche and [[Regeneron|Regeneron Pharmaceuticals]] announced a collaboration "on developing and manufacturing [[:REGN-COV2]]", Regeneron's experimental [[:monoclonal antibody]] cocktail for use against [[:COVID-19]].((Bowie, A. (2020, August 19). //Regenereon and Roche collaborate to significantly increase global supply of REGN-CoV2 investigational antibody cocktail for COVID-19.// Regeneron Pharmaceuticals. https://newsroom.regeneron.com/news-releases/news-release-details/regeneron-and-roche-collaborate-significantly-increase-global)) |
| |
| ===== External links ===== | ===== External links ===== |
| |
| * [[https://en.wikipedia.org/wiki/Roche|Wikipedia]] | * [[https://en.wikipedia.org/wiki/Roche|Wikipedia]] |
